Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 880Neoplasms 696Prostatic Neoplasms 468Lung Neoplasms 383Carcinoma, Non-Small-Cell Lung 351Colorectal Neoplasms 329Leukemia, Myeloid, Acute 278Pancreatic Neoplasms 223Neoplasm Metastasis 219Brain Neoplasms 214Multiple Myeloma 207Carcinoma, Hepatocellular 195Head and Neck Neoplasms 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 163Ovarian Neoplasms 163Glioblastoma 163Melanoma 162Squamous Cell Carcinoma of Head and Neck 159Rectal Neoplasms 137Recurrence 135Hematologic Neoplasms 131Uterine Cervical Neoplasms 130Sarcoma 128Stomach Neoplasms 124Triple Negative Breast Neoplasms 123Glioma 119Carcinoma, Renal Cell 118Urinary Bladder Neoplasms 112Colonic Neoplasms 109Myelodysplastic Syndromes 106

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × High-Risk Localized Prostate Cancer × 90 days × Clear all
NCT07550517 2026-04-24

PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Not yet recruiting
60 enrolled
Genitourinary

High-Risk Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡